Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy - Concepedia

Concepedia

Publication | Open Access

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

DOI Full Paper Access

135

Citations

67

References

2020

Year

Marianne Weulersse, Assia Asrir, Andrea Pichler, L Lemaître, Matthias Braun, Nadège Carrié, Marie-Véronique Joubert, Marie Le Moine, Laura Do Souto, Guillaume Gaud,

Eomes-dependent LossCancer ImmunosurveillanceT-regulatory CellImmunologyImmune Checkpoint InhibitorAutoimmunityImmune Cell TherapyImmunotherapyMedicineRadiation OncologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1